Meridian Bioscience, Inc. (VIVO) Misses Q4 EPS by 1c; Reaffirms FY12 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| Meridian Bioscience, Inc. (NASDAQ: VIVO) | Delayed: 1.60 -0.61 (27.6%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.21 | 52 Week High | $21.49 | |||
| Open | $2.06 | 52 Week Low | $15.75 | |||
| Day High | $2.06 | P/E | 1.82 | |||
| Day Low | $1.43 | EPS | $0.88 | |||
| Volume | 2,361,745 | |||||
